Google's TxGemma Launches, Yoda Therapeutics Trials, and GE's AI Cardiac CT - Life AI Weekly #11

Hi there, In this edition of Life AI Weekly, we're diving into the latest advancements in healthcare and life sciences AI. Yoda Therapeutics has initiated a Phase 2 trial for a treatment targeting Multiple System Atrophy (MSA), while the Oxford Institute is leveraging AI to accelerate Alzheimer's drug discovery. Meanwhile, Google has launched TxGemma, a new platform aimed at enhancing therapeutics development. On the business front, VisiQuate has acquired Rotera to automate revenue cycles using AI, and Voize has secured $9 million to advance AI speech recognition in healthcare. Additionally, GE HealthCare has unveiled a new AI-powered cardiac CT device, promising to revolutionize cardiac diagnostics. Stay tuned as we explore these stories and more in the world of AI-driven healthcare innovations.

Health In Tech announced a collaboration with DialCare to integrate virtual healthcare services into its health plans, enhancing access to telehealth for members across the U.S. VisiQuate has acquired Rotera to enhance AI-driven automation in healthcare revenue cycle management, aiming to improve operational efficiency and reduce manual tasks. On March 27, 2025, Healthee announced a partnership with Northwind Pharmaceuticals to improve prescription drug management for employers, focusing on cost control and pharmacy oversight.

Yoda Therapeutics Inc. has initiated a Phase 2 trial for YA-101, dosing the first patient in the United States. Researchers at the Oxford Drug Discovery Institute are employing AI and knowledge graphs to speed up the Alzheimer's drug discovery process. Viva Biotech has reported its 2024 financial results, showing significant revenue growth and AI advancements. Nigerian startup Autogon AI has launched a no-code AI platform for disease identification and drug discovery. On March 25, 2025, Google announced TxGemma, a set of open models for therapeutic development.

Corundum Systems Biology Inc. is supporting the launch of Pheno.AI's Human Phenotype Project in Japan, aiming to gather extensive health data from Japanese participants to boost global health research. Researchers at Washington State University have developed a machine learning model to identify animal species that may harbor viruses capable of infecting humans, focusing on orthopoxviruses.

Linearis has introduced a new high-throughput metabolomics platform in Québec City, utilizing AI to enhance the analysis of metabolic biomarkers. Semaphore Solutions has launched an AI-powered workflow configuration co-pilot for its Labbit platform at BioIT 2025, aimed at improving laboratory workflow efficiency.

The International Institute for Brain Enhancement and NeuralCure AI are collaborating on PTSD treatments for veterans using AI. Wishpond Technologies Ltd. partners with Venops Inc. to market AI-powered SalesCloser platform in healthcare. RamSoft and Alpha Nodus integrate AI tools to enhance healthcare site operations globally.